James Topper - Dec 29, 2023 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ James N. Topper
Stock symbol
NAMS
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
3
Date filed
12/29/2023, 04:30 PM
Previous filing
Dec 13, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NAMS Ordinary Shares 3.8M Dec 29, 2023 Frazier Lifesciences Sponsor LLC F1
holding NAMS Ordinary Shares 3M Dec 29, 2023 Frazier Life Sciences X, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAMS Warrant (right to buy) Dec 29, 2023 Ordinary Shares 167K $11.50 Frazier Lifesciences Sponsor LLC F1
holding NAMS Warrant (right to buy) Dec 29, 2023 Ordinary Shares 333K $11.50 Frazier Life Sciences X, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held directly by Frazier Lifesciences Sponsor LLC ("Sponsor"). The sole member of Sponsor is Frazier Life Sciences X, L.P. ("FLS X"). FHMLS X, L.P. is the general partner of FLS X and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper is one of two managing members of FHMLS X, L.L.C. Dr. Topper disclaims beneficial ownership of the securities held by FLS Sponsor except for his pecuniary interest therein, if any.
F2 The securities are held directly by FLS X. FHMLS X, L.P. is the general partner of FLS X and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper is one of two managing members of FHMLS X, L.L.C.. Dr. Topper disclaims beneficial ownership of the securities held by FLS X except for his pecuniary interest therein, if any.